According to NY Times, more than 60 percent of CBD users were taking it for anxiety, according to a survey of 5,000 people. CBD is advertised as providing relief for anxiety, depression and post-traumatic stress disorder. It is also marketed in general to promote sleep.
Last year, the FDA approved Epidiolex, a purified CBD extract, to treat rare seizure disorders in patients 2 years or older after three randomized, double-blind and placebo-controlled clinical trials with 516 patients that showed the drug, taken along with other medications, helped to reduce seizures.
Part of CBD’s popularity is that it purports to be “non-psychoactive,” and that consumers can reap health benefits from the plant without the high (or the sweet munchies).
Cannabidiol (CBD) shouldn't show up on a drug test. However, many CBD products contain trace amounts of delta-9-tetrahydrocannabinol (THC), marijuana's main active ingredient.. Some users of CBD have also failed drug tests when the product contained more THC than indicated. At HOOPLA we only use broad-spectrum CBD which means we have removed most (if not all traces) of THC.
A 2010 study indicated that CBD can reduce symptoms of Social Anxiety Disorder. In this test, the subjects' brain scans showed some changes in the blood flow to areas of the brain linked to anxiety. The use of CBD oil shows clear signs of the participants calming down.
A 2016 study found that CBD can have antipsychotic effects in people with schizophrenia. Moreover, CBD doesn’t cause the significant debilitating side effects associated with some antipsychotic drugs.
CBD is a powerful anti-inflammatory. Studies have shown that CBD may help reduce chronic pain by impacting endocannabinoid receptor activity, reducing inflammation and interacting with neurotransmitters.
People report using CBD for anxiety, pain, sleep.